New UPSC Foundation, Optional and TGPSC/APPSC batches are open — book your counselling slot.Explore coursesToday's Current AffairsToday's Daily QuizPlaces in NewsCall 98804 87071
HealthGS 2 & 3Story 9 of 10 · · 4 min read

WHO Flags AMR Implementation Gaps: Priorities for India’s One Health Response

Revise the static topic: UPSC Social Justice notes · UPSC Science & Technology notes

In short: WHO data show that 173 countries have developed antimicrobial-resistance action plans, but only 22 per cent report both adequate funding and full implementation. Closing gaps in diagnostics, surveillance and appropriate treatment requires a funded One Health response linking human, animal and environmental health.

Reference view of a scientist using a microscope in a laboratory, illustrating the diagnostic capacity needed to support an effective antimicrobial-resistance response.

Reference view of a scientist using a microscope in a laboratory, illustrating the diagnostic capacity needed to support an effective antimicrobial-resistance response.

Image: UN News

Why in news

WHO released findings from the latest Tracking Antimicrobial Resistance Country Self-assessment Survey ahead of World AMR Awareness Week, observed from 18 to 24 November. The findings highlight the gap between adopting national plans and delivering effective measures against antimicrobial resistance.

GS 2: Issues relating to development and management of health servicesGS 2: Important international institutions and their mandatesGS 3: Science and technology developments and their applicationsGS 3: Environmental pollution and degradationPrelims: Antimicrobial resistance, One Health and WHO

173

Countries reporting AMR action plans

22%

Countries reporting funding and full implementation

36%

Countries reporting specified reference-laboratory capacity

63%

Countries reporting appropriate-use guidelines

One in six

Laboratory-confirmed bacterial infections resistant in 2023

80% by 2030

Country coverage target for comprehensive resistance testing

Background

Antimicrobial resistance occurs when bacteria, viruses, fungi or parasites no longer respond adequately to medicines used against them. Antibiotic resistance is the bacterial component of this wider problem; microbes, not patients, become resistant. Resistance can emerge naturally, while inappropriate antimicrobial use accelerates selection and inadequate infection prevention enables resistant organisms to spread. Because resistant organisms and resistance determinants can move between people, animals and the environment, AMR requires a One Health approach rather than a response confined to hospitals.

What WHO’s findings establish

The number of countries reporting AMR action plans has risen from 79 in 2017 to 173. However, only 22 per cent report having both the necessary funding and full implementation, demonstrating that policy adoption is not equivalent to operational readiness.

Only 36 per cent report a national reference laboratory equipped to test the selected bacteria and fungi. WHO contrasts this gap with the global target of comprehensive bacterial and fungal resistance testing capacity in 80 per cent of countries by 2030. Appropriate-use guidelines are reported by 63 per cent, while just over half report systems to monitor national antibiotic use and track AMR.

The latest TrACSS was completed by 183 countries. These are country self-assessments, not an independent audit of every facility; the figures should not be interpreted as direct measures of population-level service coverage.

  • The one-in-six estimate concerns laboratory-confirmed bacterial infections worldwide in 2023, not all infections or all antimicrobial medicines.
  • National reference-laboratory capacity does not by itself establish that patients have affordable access to timely testing.

Infographic

From AMR plans to delivery

Finance

Fund staff, supplies and recurring service costs.

Prevent

Reduce infections through hygiene, sanitation and vaccination.

Diagnose

Provide affordable, timely and quality-assured testing.

Treat appropriately

Combine stewardship with access to essential medicines.

Integrate

Connect human, animal and environmental action.

Account

Track functioning services and corrective action.

AI-assisted infographic by Pragnya IAS Academy, based on the cited sources.

Why action plans fail to become effective services

The findings point to an implementation chain with multiple weak links. An action plan cannot deliver results without recurring expenditure on laboratory staff, reagents, sample transport, infection prevention and essential medicines. Capital investment in equipment alone is therefore insufficient.

Testing gaps can leave clinicians dependent on empirical treatment, with a greater risk of prescribing an ineffective or unnecessary antibiotic. Empirical treatment may be clinically necessary, especially in severe illness; the objective is timely testing and subsequent treatment review, not delaying urgent care.

Guidelines also need institutional support. Without prescription review, reliable local resistance data, trained teams and access to recommended medicines, written guidance may not change practice. Surveillance remains incomplete when reporting systems exclude important providers or fail to connect findings with clinical and public-health action.

  • Funding should cover the operating costs of services, not merely the preparation of plans.
  • Laboratory results must reach treating teams in time to influence decisions.
  • Surveillance must produce actionable feedback rather than function only as a reporting exercise.
Reference view of an outpatient consultation at the Community Health Centre in Rama, Jhabua district, Madhya Pradesh, India. Accessible clinical services are essential to translating action plans into appropriate treatment.

Reference view of an outpatient consultation at the Community Health Centre in Rama, Jhabua district, Madhya Pradesh, India. Accessible clinical services are essential to translating action plans into appropriate treatment.

Image: UN News

Why India needs a funded One Health approach

For India, the policy priority is to translate One Health into shared budgets, responsibilities and measurable outputs across human health, animal husbandry, agriculture and environmental management. This is an implementation recommendation, not evidence from the source of India’s performance in the survey.

Public health and sanitation are primarily State subjects, making State and local implementation indispensable. Union-level coordination, standards and technical support must be matched by State-level delivery and cooperation across departments.

A hospital-only approach would leave important pathways unaddressed. Responsible veterinary antimicrobial use, animal disease prevention, safe water and sanitation, and management of healthcare, pharmaceutical and livestock waste should complement human-health interventions.

  • Link human, animal and relevant environmental surveillance while retaining appropriate sampling and quality standards.
  • Create costed State and district implementation plans with identified departmental responsibilities.
  • Include private laboratories, hospitals, pharmacies and veterinary providers in implementation arrangements.

The central policy balance: access and stewardship

AMR control must reduce inappropriate use without denying effective treatment to patients who need it. Restriction alone is inadequate if diagnostics are unaffordable or recommended medicines are unavailable.

Infection prevention offers a complementary route: preventing infections reduces the need for antimicrobial treatment. WHO therefore emphasises investment in infection prevention, surveillance, equitable access to essential antimicrobials and quality diagnostics.

Accountability should move beyond counting plans and guidelines. India should assess whether laboratory networks function, results guide treatment, essential medicines remain available and surveillance triggers corrective action.

  • Stewardship should optimise medicine choice, dose and duration, rather than seek indiscriminate reductions in use.
  • Performance assessment should distinguish policy adoption, service availability and patient outcomes.
  • Lower reported resistance may reflect inadequate testing and should not automatically be treated as better performance.
Reference view of medicine bottles, pills, capsules and blister packs, illustrating the policy challenge of ensuring access to medicines while promoting appropriate prescribing and use.

Reference view of medicine bottles, pills, capsules and blister packs, illustrating the policy challenge of ensuring access to medicines while promoting appropriate prescribing and use.

Image: UN News

From AMR policy commitments to measurable delivery
Policy componentImplementation requirementSuggested accountability measure
National and State action plansCosted activities, recurring finance and assigned responsibilitiesBudget execution and completion of funded activities
Diagnostic capacityQuality-assured laboratories, sample transport and affordable testingTesting access, quality performance and turnaround time
SurveillanceRepresentative reporting linked to clinical and public-health decisionsReporting coverage, data completeness and action taken
Appropriate treatmentStewardship teams, usable guidelines and essential medicine availabilityPrescription appropriateness and treatment review
One Health coordinationJoint human, animal and environmental actionShared reviews and delivery of cross-sectoral interventions
Turning an AMR plan into a functioning response
  1. 1. Identify implementation gaps and assign cross-sectoral responsibilities.
  2. 2. Provide costed, predictable funding for staff, supplies and services.
  3. 3. Strengthen infection prevention, diagnostics and equitable medicine access.
  4. 4. Generate quality-assured resistance and antimicrobial-use data.
  5. 5. Use results to guide treatment, stewardship and outbreak response.
  6. 6. Review outcomes and redirect resources towards unresolved gaps.
Timeline
  1. 2017

    WHO’s comparison records 79 countries reporting AMR action plans.

  2. 2023

    Around one in six laboratory-confirmed bacterial infections worldwide were resistant to antibiotics.

  3. Latest TrACSS release

    The survey was completed by 183 countries; 173 countries report action plans, but only 22 per cent report both funding and full implementation.

  4. 2030

    The global target is comprehensive bacterial and fungal resistance testing capacity in 80 per cent of countries.

Significance, challenges & way forward

Significance

  • Effective AMR control protects the safety of surgery, childbirth and cancer care, which depend on preventing and treating infections.
  • Quality diagnostics support appropriate treatment and help identify resistant infections and outbreaks.
  • A One Health approach addresses connected risks across people, animals and the environment.
  • Affordable testing and effective medicines make AMR control integral to equitable healthcare.

Challenges

  • Plans without predictable operational funding cannot sustain laboratory networks or frontline implementation.
  • Inadequate testing can distort surveillance and conceal the true distribution of resistant infections.
  • Fragmented responsibilities can weaken coordination across health, veterinary and environmental authorities.
  • Guidelines may have limited effect without training, prescription review and access to recommended treatment.
  • Poorly designed restrictions can reduce legitimate access while leaving the drivers of inappropriate use unresolved.

Way forward

  • Translate AMR commitments into costed State and district plans backed by recurring budgets and clearly assigned responsibilities.
  • Build tiered laboratory networks with sample referral, quality assurance and timely communication of results.
  • Strengthen representative surveillance across public and private providers and connect findings with clinical guidance.
  • Institutionalise stewardship through treatment review, prescription audit and context-appropriate guidelines.
  • Integrate vaccination, infection prevention, water, sanitation and hygiene into AMR financing.
  • Fund joint human, animal and environmental interventions, including responsible veterinary use and waste management.
  • Assess progress through service delivery and patient-relevant outcomes, with independent validation where feasible.

Key terms

Antimicrobial resistance
Reduced responsiveness of microorganisms to medicines intended to prevent or treat infections.
One Health
An integrated approach recognising the interdependence of human, animal and ecosystem health.
Antimicrobial stewardship
Coordinated measures to optimise antimicrobial use while ensuring effective treatment.
TrACSS
Tracking Antimicrobial Resistance Country Self-assessment Survey, used to assess countries’ reported progress on AMR.
Antimicrobial susceptibility testing
Laboratory testing to determine how a microorganism responds to particular antimicrobial medicines.
Empirical treatment
Treatment selected using clinical assessment and likely pathogens before definitive laboratory results are available.

Link with static syllabus

Seventh Schedule: State List provisions on public health and sanitationArticle 47: State responsibility to improve public healthWHO and international health governanceMicrobial evolution and selection pressureOne Health and zoonotic disease preventionWater, sanitation, hygiene and infection prevention
Revise these in the free Study Library →

Prelims practice MCQs

  1. Q1. With reference to antimicrobial resistance, consider the following statements: 1. Resistance develops in microorganisms rather than in the human body itself. 2. Antibiotic resistance includes resistance in bacteria, viruses, fungi and parasites. 3. Preventing infections can reduce the need for antimicrobial medicines. Which of the statements given above are correct?

  2. Q2. Which of the following best describes the Tracking Antimicrobial Resistance Country Self-assessment Survey?

  3. Q3. Consider the following measures: 1. Improving infection prevention in hospitals 2. Promoting responsible veterinary antimicrobial use 3. Managing pharmaceutical and healthcare waste Which of the above can form part of a One Health response to AMR?

  4. Q4. With reference to the WHO findings supplied in the report, consider the following statements: 1. The one-in-six estimate refers to laboratory-confirmed bacterial infections worldwide in 2023. 2. Reporting a national reference laboratory establishes universal patient access to resistance testing. Which of the statements given above is/are correct?

Mains practice questions

GS 2 · 15 marks · 250 words

National action plans on antimicrobial resistance are necessary but insufficient. Examine the implementation gaps highlighted by WHO and suggest priorities for a funded One Health response in India.

Frequently asked questions

What is the main implementation gap highlighted by WHO?

Action plans have expanded, but funding and full implementation remain limited. WHO also identifies gaps in testing capacity, appropriate-use guidelines and surveillance.

Does AMR mean that a patient becomes resistant to antibiotics?

No. Microorganisms become resistant to medicines; the patient’s body does not become antibiotic-resistant.

Why is One Health important for India’s AMR response?

Human health, animal health and environmental pathways are interconnected. Coordinated financing and implementation can address risks that hospital-focused measures alone cannot.

Should antibiotics always be withheld until laboratory results arrive?

No. Clinically indicated empirical treatment may be necessary, particularly in severe illness, followed by timely review using diagnostic results and clinical progress.

Sources

Analysis prepared by the Pragnya IAS Academy current-affairs desk with AI assistance from the cited reports. Verify figures with the original sources.

Turn current affairs into marks

Join Pragnya IAS Academy's mentorship for daily answer-writing evaluation on stories like this — classroom programmes from a trusted name in IAS coaching in Hyderabad.

Free UPSC daily current affairs quiz — 10 questions, new every day at 8 am IST.

Call nowWhatsApp